<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36976485</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Introduction to the 'long COVID' special issue.</ArticleTitle><Pagination><StartPage>549</StartPage><MedlinePgn>549</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-023-01197-x</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>Sandor</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 E. Hill, Signal Hill/Long Beach, CA, 90755, USA. sszabo@auhs.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyires</LastName><ForeName>Klara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Semmelweis University, Faculty of Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayachkivska</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4309-2473</Identifier><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 E. Hill, Signal Hill/Long Beach, CA, 90755, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have not disclosed any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36976485</ArticleId><ArticleId IdType="pmc">PMC10043516</ArticleId><ArticleId IdType="doi">10.1007/s10787-023-01197-x</ArticleId><ArticleId IdType="pii">10.1007/s10787-023-01197-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>